Trinity Biotech plc (NASDAQ:TRIB), might not be a large cap stock, but it received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$1 ...

Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update. DUBLIN, May 15, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a ...

Review Trinity Biotech PLC ADR (TRIB:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.

Trinity Biotech plc announced revised agreements with its primary lender, Perceptive Advisors, to improve its financial position as the company implements its Comprehensive Transformation Plan ...

Trinity Biotech’s deal values Metabolomics Diagnostics at approximately $1.3 million. Trinity Biotech will pay the amount with just over 270,000 Trinity Biotech plc’s American Depositary ...

Trinity Biotech plc (NASDAQ:TRIB) Q2 2024 Earnings Call Transcript August 16, 2024 Operator: Welcome to the Trinity Biotech Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As ...

--Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter ...

Trinity Biotech plc (NASDAQ:TRIB) Q4 2023 Earnings Conference Call April 4, 2024 8:00 AM ET. Company Participants. John Gillard - Chief Executive Officer Des Fitzgerald - Chief Financial Officer ...

DUBLIN, Ireland, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and ...

Trinity Biotech plc (NASDAQ:TRIB) M&A and Q3 2023 Results Conference Call January 31, 2024 8:30 AM ET. Company Participants. Eric Ribner - Managing Director, LifeSci Advisors ...

Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the ...